Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001860782-25-000037
Filing Date
2025-05-07
Accepted
2025-05-07 16:16:20
Documents
80
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tsvt-20250331.htm   iXBRL 10-Q 994008
2 EX-31.1 tsvt-q1202510xqexhibit311cb.htm EX-31.1 8968
3 EX-31.2 tsvt-q1202510xqexhibit312ve.htm EX-31.2 9059
4 EX-32.1 tsvt-q1202510xqexhibit321.htm EX-32.1 5779
  Complete submission text file 0001860782-25-000037.txt   6583543

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tsvt-20250331.xsd EX-101.SCH 56507
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tsvt-20250331_cal.xml EX-101.CAL 70756
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tsvt-20250331_def.xml EX-101.DEF 286610
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tsvt-20250331_lab.xml EX-101.LAB 616815
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tsvt-20250331_pre.xml EX-101.PRE 444398
83 EXTRACTED XBRL INSTANCE DOCUMENT tsvt-20250331_htm.xml XML 893425
Mailing Address 60 BINNEY STREET CAMBRIDGE MA 02210
Business Address 60 BINNEY STREET CAMBRIDGE MA 02210 339-499-9300
2seventy bio, Inc. (Filer) CIK: 0001860782 (see all company filings)

EIN.: 863658454 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40791 | Film No.: 25921618
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)